Form D · Biotechnology
Islet Sciences, Inc.
Yorba Linda, CA · CIK 0001425919
Offering snapshot reported Dec 31, 2015 · SEC filing
- Reported sold
- $30K Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 18, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2015 | Initial | $30,000 | No comparison | 1 | SEC filing |
| Apr 28, 2014 | Amendment | $2,222,500 | $0vs Apr 25, 2014 | 35 | SEC filing |
| Apr 25, 2014 | Amendment | $2,222,500 | $1,527,500vs Feb 25, 2014 | 35 | SEC filing |
| Feb 25, 2014 | Initial | $695,000 | No comparison | 22 | SEC filing |
| May 15, 2012 | Amendment | $4,222,265 | $2,818,750vs Apr 5, 2012 | 71 | SEC filing |
| Apr 5, 2012 | Initial | $1,403,515 | No comparison | 17 | SEC filing |
| Mar 16, 2012 | Initial | $1 | No comparison | 28 | SEC filing |
| Jan 11, 2012 | Initial | $1 | No comparison | 71 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $165K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-254317
Includes cash and value of warrants. Estimated amount listed assumes maximum aggregate amount of securities sold.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cova Capital Partners, LLC | 109761 |
Source: Form D, filed Dec 31, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Barnett | Director |
| Richard Egan | Executive |
| Larry K. Ellingson | Director, Executive |
| James Green | Director, Executive |
| James A. Harper | Director |
| Gary R. Keeling | Director |
| Jonathan Lakey | Director |
| Michael Luther | Director |
| Eugene M. Mannheimer | Director |
| Jerry Nadler | Director |
| Joel Perlin | Director |
| Richard D. Pilnik | Director |
| John F. Steel | Director |
| George Todaro | Director |
| David E. Wilder | Executive |
| William Wilkison | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
18340 Yorba Linda Blvd. Suite 107 245
Yorba Linda, CA, 92886
Yorba Linda, CA, 92886